Navigation Links
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
Date:10/5/2010

ometabolism.  Numerous studies have shown that an early feature of AD is region-specific declines in cerebral glucose metabolism.  One strategy to treat this condition has been to supplement the brain's normal glucose supply with ketone bodies.

"Accera is in a period of significant growth in both the commercialization of Axona and development of clinical trials with AC-1204.  I look forward to leading the Company in both efforts," said Dr. Werner.  "The IND acceptance for AC-1204 represents a further validation of Accera's methods, research and commitment to advancing novel therapeutic alternatives for Alzheimer's disease.  We expect the ALERT study will further demonstrate the long-term benefits of Accera's approach to Alzheimer's."

About AC-1204

AC-1204 targets the metabolic deficiencies and imbalances associated with Alzheimer's disease by providing ketone bodies as an alternative energy source for brain cells that have defective glucose metabolism.  This approach has been shown to safely improve cognitive function and memory in AD patients and in pre-clinical animal models of dementia.

About Axona®

Axona is a prescription-only medical food intended for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer's disease.  For more information, visit www.about-axona.com

About Accera, Inc.

Accera, Inc. is a privately held commercial-stage biotechnology company that developed and now markets Axona in the U.S.  Accera is engaged in the research, development and commercialization of other clinical applications for Axona and AC-1204 in acute and chronic neurodegenerative diseases.  For more information about Accera, please visit www.accerapharma.com.Company contact:Accera, Inc.(303) 999-3705Bill PoncyVP Commercial Development

SOURCE Accera, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Accera, Inc. To Present at Lazard Capital Markets 6th Annual Healthcare Conference
2. Quark Pharmaceuticals Appoints New Chief Medical Officer
3. West Pharmaceutical Services, Inc. Appoints New Director
4. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
5. Curemark Appoints Preeminent Pediatrics Gastroenterologist
6. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
9. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
10. NovaRx Appoints Industry Veteran as President and COO
11. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... BURLINGTON, Mass. , May 21, 2013 ... leading research and advisory firms for pharmaceutical ... of an emerging agent on key efficacy ... disease progression, has the most influence over ... for advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast ...
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)... 21, 2013  The North Shore-LIJ Health System is ... hand-washing compliance at North Shore University Hospital in ... operating rooms at Forest Hills ... The new pilot program strengthens patient safety by ... (ORs), the first time in the US that remote ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... June 1, 2011 Mirixa Corporation is pleased to ... licensing agreement for MirixaEdge(SM), a clinical application that supports ... Medication Therapy Management (MTM). Family Physicians Group (FPG), ... Source Pharmacy and selected it as FPG,s preferred pharmacy ...
... YORK, June 1, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0305172/Global-Intravenous-IV-Iron-Drugs-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... Intravenous (IV) Iron Drugs in US$ Million. ...
Cached Medicine Technology:MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 3Global Intravenous (IV) Iron Drugs Industry 2Global Intravenous (IV) Iron Drugs Industry 3Global Intravenous (IV) Iron Drugs Industry 4Global Intravenous (IV) Iron Drugs Industry 5Global Intravenous (IV) Iron Drugs Industry 6Global Intravenous (IV) Iron Drugs Industry 7
(Date:5/21/2013)... Residents in St. Petersburg, FL have a new ... David Sherberg, DMD, has joined Coast Dental Pasadena, located ... preventive, restorative and cosmetic dentistry to patients age 12 ... a wide variety of services including teeth ... bridges, dentures, dental implant restorations, veneers, laser therapy, oral ...
(Date:5/21/2013)... 21, 2013 Three major Ohio universities and four ... to establish a new collaborative research program aimed exclusively ... March of Dimes intends to invest $10 million in ... of Dimes Prematurity Research Center -- Ohio Collaborative is ... President of the March of Dimes. "This new transdisciplinary, ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Healthcare industry ... at the premier “Start Me Up” Emerging Healthcare Technology ... Education in Madison, Wisconsin. This new event is ... a gathering of national healthcare leaders being held June ... the University of Wisconsin. , Funding for healthcare information ...
(Date:5/21/2013)... Austin, TX (PRWEB) May 21, 2013 It’s ... off to summer camp or starting practice for summer or ... required before camp or sporting activities can begin. , ... an affordable option for youth sports or camp physicals ... MedSpring’s on-site doctors will review a child’s medical history, perform ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Everspark Interactive, ... firms, has been growing rapidly over the past year ... was hired to spearhead interactive marketing efforts for Kids ... , Everspark started as a local effort, specializing ... guiding search traffic to a company's website. The company ...
Breaking Medicine News(10 mins):Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3Health News:“Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Everspark Named Interactive Marketing Company for Kids II 2
... ward off obesity as children get older.// The ... data available on breastfeeding and weight of children ... at clarifying the situation. In both, investigators followed ... see how breastfeeding impacts weight. Detailed breastfeeding histories ...
... the rejection of being picked last for a sports team, ... or being turned down for a date. //Whatever the social ... in our heads. ,According to researchers, the brain seems ... same way ,as physical pain. To study this phenomenon, investigators ...
... for cancer complain of feeling weak //and tried, and ... symptoms. A new study suggests that may not be ... with worse prognosis after radiotherapy, the doctors assumed the ... of the therapy, as well., ,Not so, report ...
... complain of feeling weak and tired,// and doctors often ... new study suggests that may not be a good ... prognosis after radiotherapy, the doctors assumed the treatment would ... therapy, as well., ,Not so, report German researchers ...
... took the drug earlier than suggested may have done migraine ... the medication works best when taken at the first sign ... severe, as was the requirement of the original study., ... agonists for the treatment of migraine have required patients to ...
... shows drug-emitting stents are effective at keeping arteries open in ... coated with the drug sirolimus. It is an immunosuppressive agent. ... the artery from closing again.// ,Stents are used to ... very useful. However, in 30 percent of patients with diabetes, ...
Cached Medicine News:Health News:Pain of Denial Compared to Physical Pain 2
Open blade design with aspiration capabilities for removing fluids from the operative site....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 15 mm....
Replacement snares for the E3525. 3 per package....
Medicine Products: